[1]
„CUT OFF VALUE OF PROCALCITONIN IN END STAGE RENAL DISEASE PATIENTS WITHOUT INFECTION”, Pak J Kidney Dis, köt. 5, sz. 02, o. 48–53, jún. 2021, doi: 10.53778/pjkd502144.